New Releases from NCBI BookshelfComparing the Effectiveness of Electronic Symptom Monitoring versus Usual Care in Improving Survival among Patients with Metastatic Cancer—The PRO-TECT Trial [Internet].​Comparing the Effectiveness of Electronic Symptom Monitoring versus Usual Care in Improving Survival among Patients with Metastatic Cancer—The PRO-TECT Trial [Internet].

Patients commonly have symptoms during cancer treatment that can go undetected. Symptom monitoring with electronic patient-reported outcome (ePRO) surveys may detect symptoms early and prompt clinicians to intervene, thereby improving outcomes.

​ 

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top